Clinical Trial Update: Biomarkers of Cockroach Sublingual Immunotherapy 2 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial update reporting biomarker findings from cockroach sublingual immunotherapy in asthma and perennial allergic rhinitis, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma, Perennial Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-30